Skip to Main Content
Table 3.

Risk factors for absence of health care utilization reported by HCT survivors

Risk factorsEntire cohort
Allogeneic HCT
Autologous HCT
GPECancer/HCT–related visitGPECancer/HCT–related visitGPECancer/HCT–related visit
Type of transplant       
    Autologous 1.00 1.00     
    Allogeneic 1.72 (1.1-2.6) 0.49 (0.3-0.9)     
Race       
    Non-Hispanic White  1.00  1.00   
    Hispanic White  0.23 (0.1-0.6)  0.16 (0.04-0.6)   
    Others  0.67 (0.3-1.7)  0.66 (0.2-2.1)   
Follow-up years       
    2-5 1.00 1.00 1.00 1.00  1.00 
    6-10 0.65 (0.5-0.9) 5.15 (2.7-9.7) 0.44 (0.3-0.8) 6.82 (1.9-24.5)  4.75 (2.3-10.1) 
    11+ 0.57 (0.4-0.9) 19.06 (9.8-37.1) 0.54 (0.3-0.9) 23.82 (6.6-86.5)  9.16 (3.7-22.7) 
    Ptrend 0.004 <0.0001 0.01 <0.001  <0.001 
Concerns of future health       
    Concerned  1.00  1.00  1.00 
    Not concerned  4.05 (1.8-9.3)  9.69 (2.1-45.3)  2.92 (1.1-7.5) 
Current health status       
    Good 1.00 1.00 1.00    
    Fair/poor 1.89 (1.3-2.7) 0.51 (0.3-0.97) 2.06 (1.3-3.4)    
Exposure to cyclosporin A       
    No exposure    1.00   
    Exposed    0.36 (0.2-0.7)   
Exposure to TBI       
    No exposure     1.00  
    Exposed     1.64 (1.0-2.7)  
Risk factorsEntire cohort
Allogeneic HCT
Autologous HCT
GPECancer/HCT–related visitGPECancer/HCT–related visitGPECancer/HCT–related visit
Type of transplant       
    Autologous 1.00 1.00     
    Allogeneic 1.72 (1.1-2.6) 0.49 (0.3-0.9)     
Race       
    Non-Hispanic White  1.00  1.00   
    Hispanic White  0.23 (0.1-0.6)  0.16 (0.04-0.6)   
    Others  0.67 (0.3-1.7)  0.66 (0.2-2.1)   
Follow-up years       
    2-5 1.00 1.00 1.00 1.00  1.00 
    6-10 0.65 (0.5-0.9) 5.15 (2.7-9.7) 0.44 (0.3-0.8) 6.82 (1.9-24.5)  4.75 (2.3-10.1) 
    11+ 0.57 (0.4-0.9) 19.06 (9.8-37.1) 0.54 (0.3-0.9) 23.82 (6.6-86.5)  9.16 (3.7-22.7) 
    Ptrend 0.004 <0.0001 0.01 <0.001  <0.001 
Concerns of future health       
    Concerned  1.00  1.00  1.00 
    Not concerned  4.05 (1.8-9.3)  9.69 (2.1-45.3)  2.92 (1.1-7.5) 
Current health status       
    Good 1.00 1.00 1.00    
    Fair/poor 1.89 (1.3-2.7) 0.51 (0.3-0.97) 2.06 (1.3-3.4)    
Exposure to cyclosporin A       
    No exposure    1.00   
    Exposed    0.36 (0.2-0.7)   
Exposure to TBI       
    No exposure     1.00  
    Exposed     1.64 (1.0-2.7)  
Close Modal

or Create an Account

Close Modal
Close Modal